Scientists test if antibody drug interferes with COVID vaccine
NCT ID NCT04852978
Summary
This study aimed to understand if giving a COVID-19 antibody treatment (casirivimab+imdevimab) affects the body's immune response to the Moderna mRNA-1273 vaccine. Researchers enrolled 295 healthy adults to receive the vaccine at different times after the antibody treatment. The main goal was to see if the antibody treatment changed how well the vaccine worked and to check the safety of giving both treatments close together.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regeneron Research Site
Little Rock, Arkansas, 72211, United States
-
Regeneron Research Site
Rogers, Arkansas, 72758, United States
-
Regeneron Research Site
Hialeah, Florida, 33012, United States
-
Regeneron Research Site
Miami, Florida, 33186, United States
-
Regeneron Research Site
Orlando, Florida, 32789, United States
-
Regeneron Research Site
Dayton, Ohio, 45417, United States
Conditions
Explore the condition pages connected to this study.